Purification and characterization of tissue plasminogen activator kringle-2 domain expressed in Escherichia coli
- PMID: 2497771
- DOI: 10.1021/bi00430a068
Purification and characterization of tissue plasminogen activator kringle-2 domain expressed in Escherichia coli
Abstract
We have expressed the 174-263 fragment (kringle-2 domain) of human tissue-type plasminogen activator (t-PA) in Escherichia coli by secretion into the periplasmic space using the alkaline phosphatase promoter and stII enterotoxin signal sequence. A large portion of the secreted protein is associated with an insoluble cellular fraction. This material can be solubilized by extraction with denaturant and reducing agent and then recovered in active form by refolding in the presence of reduced and oxidized glutathione. Kringle-2 is then easily purified by affinity chromatography on lysine-Sepharose followed by cation-exchange chromatography. The isolated protein has an amino acid composition and N-terminal sequence as expected for the 174-263 fragment of t-PA, indicating that the signal peptide has been properly removed. Circular dichroic spectra suggest that the protein is folded similar to the kringle-4 domain of plasminogen [Castellino et al. (1986) Arch. Biochem. Biophys. 247, 312-320]. Equilibrium dialysis experiments indicate a single binding site on kringle-2 for L-lysine having a KD of 100 microM. Using a method based on elution of kringle from lysine-Separose with omega-aminocarboxylic acids [Winn et al. (1980) Eur. J. Biochem. 104, 579-586], we have shown the lysine binding site of t-PA kringle-2 to have a preference for a ligand with 8.8-A separation between amine and carboxylate functions. Charge interactions with the epsilon-amino group of L-lysine are important in binding since the affinities for N epsilon-acetyl-L-lysine, L-arginine, and gamma-guanidinobutyric acid are decreased greater than 2000-fold, 200-fold, and 12-fold, respectively, relative to the affinity for L-lysine.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Functional properties of the recombinant kringle-2 domain of tissue plasminogen activator produced in Escherichia coli.J Biol Chem. 1990 Aug 25;265(24):14606-11. J Biol Chem. 1990. PMID: 2117612
-
Domain-domain interactions in hybrids of tissue-type plasminogen activator and urokinase-type plasminogen activator.Protein Eng. 1995 Dec;8(12):1295-1302. doi: 10.1093/protein/8.12.1295. Protein Eng. 1995. PMID: 8869642
-
Expression, purification, and characterization of the recombinant kringle 1 domain from tissue-type plasminogen activator.Arch Biochem Biophys. 1992 Apr;294(1):282-90. doi: 10.1016/0003-9861(92)90170-2. Arch Biochem Biophys. 1992. PMID: 1550352
-
1H NMR structural characterization of a recombinant kringle 2 domain from human tissue-type plasminogen activator.Biochemistry. 1989 Nov 28;28(24):9350-60. doi: 10.1021/bi00450a016. Biochemistry. 1989. PMID: 2558718
-
Structure and function of human tissue-type plasminogen activator (t-PA).J Cell Biochem. 1986;32(3):169-78. doi: 10.1002/jcb.240320302. J Cell Biochem. 1986. PMID: 3097031 Review.
Cited by
-
Recent tPA administration can cause pseudo-hyperargininemia and may mimic arginase deficiency or arginine supplementation.JIMD Rep. 2022 Oct 13;63(6):563-567. doi: 10.1002/jmd2.12328. eCollection 2022 Nov. JIMD Rep. 2022. PMID: 36341162 Free PMC article.
-
Overview of the purification of recombinant proteins.Curr Protoc Protein Sci. 2015 Apr 1;80:6.1.1-6.1.35. doi: 10.1002/0471140864.ps0601s80. Curr Protoc Protein Sci. 2015. PMID: 25829302 Free PMC article. Review.
-
Characterization of a subunit structure and stability of the recombinant porin from Neisseria gonorrhoeae.J Protein Chem. 1998 Oct;17(7):719-28. doi: 10.1007/BF02780975. J Protein Chem. 1998. PMID: 9853688
-
Crystal structure of vitelline membrane outer layer protein I (VMO-I): a folding motif with homologous Greek key structures related by an internal three-fold symmetry.EMBO J. 1994 Mar 1;13(5):1003-10. doi: 10.1002/j.1460-2075.1994.tb06348.x. EMBO J. 1994. PMID: 8131734 Free PMC article.
-
The contribution of L-arginine to the neurotoxicity of recombinant tissue plasminogen activator following cerebral ischemia: a review of rtPA neurotoxicity.J Cereb Blood Flow Metab. 2010 Nov;30(11):1804-16. doi: 10.1038/jcbfm.2010.149. Epub 2010 Aug 25. J Cereb Blood Flow Metab. 2010. PMID: 20736961 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources